DRW Securities’s BioRestorative Therapies BRTX Stock Holding History

DRW Securities’s Portfolio BRTX Stock Details BRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-46,665	Closed	-$54.8K	–	1322
2025 Q4	$54.8K	Buy	+46,665	New	+$62.1K	﹤0.01%	1109

Other funds holding BRTX

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wealth Alliance Mellville, New York $1.2B AUM 26.51% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

DRW Securities's BRTX Position: Q1 2026 in Review

DRW Securities sold out of BioRestorative Therapies (BRTX) in Q1 2026, closing a stake of 46,665 shares — an estimated $54.8K sold.

DRW Securities first reported a position in BRTX in Q4 2025 and held it in 1 quarter. The position peaked at $54.8K in Q4 2025. 11 funds tracked by Wall St. Rank hold BRTX as of Q1 2026.

DRW Securities reported no remaining BioRestorative Therapies position as of Q1 2026 after selling out during the quarter.
DRW Securities sold 46,665 BioRestorative Therapies shares in Q1 2026, an estimated $54.8K.
DRW Securities first reported a position in BioRestorative Therapies in Q4 2025 and held it in 1 quarter.
DRW Securities's BioRestorative Therapies position peaked at $54.8K in Q4 2025.
11 funds tracked by Wall St. Rank held BioRestorative Therapies as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.